7N65 image
Deposition Date 2021-06-07
Release Date 2021-07-28
Last Version Date 2024-11-13
Entry Detail
PDB ID:
7N65
Title:
Complex structure of HIV superinfection Fab QA013.2 and BG505.SOSIP.664
Biological Source:
Source Organism:
Host Organism:
Method Details:
Experimental Method:
Resolution:
4.15 Å
Aggregation State:
PARTICLE
Reconstruction Method:
SINGLE PARTICLE
Macromolecular Entities
Polymer Type:polypeptide(L)
Molecule:Envelope glycoprotein gp41
Gene (Uniprot):env
Mutations:T332N
Chain IDs:A, E, I
Chain Length:508
Number of Molecules:3
Biological Source:Human immunodeficiency virus 1
Polymer Type:polypeptide(L)
Molecule:Envelope glycoprotein gp41
Gene (Uniprot):env
Chain IDs:B, F, J
Chain Length:161
Number of Molecules:3
Biological Source:Human immunodeficiency virus 1
Polymer Type:polypeptide(L)
Molecule:Fab QA013.2 Heavy Chain, variable region
Chain IDs:C, G, K
Chain Length:128
Number of Molecules:3
Biological Source:Homo sapiens
Polymer Type:polypeptide(L)
Molecule:Fab QA013.2 Light Chain, , variable region
Chain IDs:D, H, L
Chain Length:108
Number of Molecules:3
Biological Source:Homo sapiens
Primary Citation
Functional development of a V3/glycan-specific broadly neutralizing antibody isolated from a case of HIV superinfection.
Elife 10 ? ? (2021)
PMID: 34263727 DOI: 10.7554/eLife.68110

Abstact

Stimulating broadly neutralizing antibodies (bnAbs) directly from germline remains a barrier for HIV vaccines. HIV superinfection elicits bnAbs more frequently than single infection, providing clues of how to elicit such responses. We used longitudinal antibody sequencing and structural studies to characterize bnAb development from a superinfection case. BnAb QA013.2 bound initial and superinfecting viral Env, despite its probable naive progenitor only recognizing the superinfecting strain, suggesting both viruses influenced this lineage. A 4.15 Å cryo-EM structure of QA013.2 bound to native-like trimer showed recognition of V3 signatures (N301/N332 and GDIR). QA013.2 relies less on CDRH3 and more on framework and CDRH1 for affinity and breadth compared to other V3/glycan-specific bnAbs. Antigenic profiling revealed that viral escape was achieved by changes in the structurally-defined epitope and by mutations in V1. These results highlight shared and novel properties of QA013.2 relative to other V3/glycan-specific bnAbs in the setting of sequential, diverse antigens.

Legend

Protein

Chemical

Disease

Primary Citation of related structures